Edition:
United Kingdom

Acasti Pharma Inc (ACST.OQ)

ACST.OQ on NASDAQ Stock Exchange Capital Market

0.86USD
17 May 2019
Change (% chg)

$-0.01 (-0.83%)
Prev Close
$0.86
Open
$0.86
Day's High
$0.87
Day's Low
$0.85
Volume
38,553
Avg. Vol
63,157
52-wk High
$1.80
52-wk Low
$0.43

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 1 0.09 0.09 0.09 --
Quarter Ending Dec-19 1 0.09 0.09 0.09 --
Year Ending Mar-19 2 0.00 0.00 0.00 3.24
Year Ending Mar-20 1 1.28 1.28 1.28 0.00
Earnings (per share)
Quarter Ending Sep-19 1 -0.07 -0.07 -0.07 --
Quarter Ending Dec-19 1 -0.06 -0.06 -0.06 --
Year Ending Mar-19 3 -0.53 -0.21 -0.84 -0.69
Year Ending Mar-20 1 -0.25 -0.25 -0.25 -0.71
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 54.03 55.51
P/E High - Last 5 Yrs. -- 50.49 58.09
P/E Low - Last 5 Yrs. -- 27.02 28.17
Beta -- 0.97 0.96
Price to Sales (TTM) -- 7.48 9.49
Price to Book (MRQ) -- 3.44 4.12
Price to Tangible Book (MRQ) -- 3.75 4.94
Price to Cash Flow (TTM) -- 37.76 37.74
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.88 1.69
Dividend Yield - 5 Year Avg -- 0.74 0.73
Dividend 5 Year Growth Rate -- 2.34 3.14
Payout Ratio(TTM) -- 16.20 15.84

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 12.90 15.47
Sales (TTM) vs TTM 1 Yr. Ago -- 6.11 8.33
Sales - 5 Yr. Growth Rate -- 9.35 10.55
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 18.51 18.81
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 5.68 7.31
Capital Spending - 5 Yr. Growth Rate -- 7.37 8.46

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.39 2.41
Current Ratio (MRQ) -- 3.33 3.33
LT Debt to Equity (MRQ) -- 13.48 14.29
Total Debt to Equity (MRQ) -- 18.23 19.61
Interest Coverage (TTM) -- 8.57 14.97

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 51.83 50.23
Gross Margin - 5 Yr. Avg. -- 50.41 51.03
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 17.36 15.85
Operating Margin (TTM) -- 0.31 -5.48
Operating Margin - 5 Yr. Avg. -- 13.52 11.05
Pre-Tax Margin (TTM) -- -0.00 -5.74
Pre-Tax Margin - 5 Yr. Avg. -- 19.70 16.06
Net Profit Margin (TTM) -- -3.70 -9.55
Net Profit Margin - 5 Yr. Avg. -- 14.80 11.26
Effective Tax Rate (TTM) -- 20.31 20.60
Effective Tax Rate - 5 Yr. Avg. -- 22.43 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 856,648,057 719,019,170
Net Income/Employee (TTM) -- 100,100,167 83,985,523
Receivable Turnover (TTM) -- 5.29 5.61
Inventory Turnover (TTM) -- 2.47 3.67
Asset Turnover (TTM) -- 0.81 0.77

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 9.58 9.33
Return on Assets - 5 Yr. Avg. -- 10.78 10.30
Return on Investment (TTM) -- 11.89 11.59
Return on Investment - 5 Yr. Avg. -- 13.74 13.13
Return on Equity (TTM) -- 13.19 16.33
Return on Equity - 5 Yr. Avg. -- 15.07 14.72
Note: Units in Millions of US Dollars

Performance for Acasti Pharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.